133 related articles for article (PubMed ID: 12168931)
21. Prognostic significance of infiltrating immune cell subtypes in invasive ductal carcinoma of the breast.
Xu Y; Lan S; Zheng Q
Tumori; 2018 Jun; 104(3):196-201. PubMed ID: 28430349
[TBL] [Abstract][Full Text] [Related]
22. Double immunolabeling with cytokeratin and smooth-muscle actin in confirming early invasive carcinoma of breast.
Prasad ML; Hyjek E; Giri DD; Ying L; O'Leary JJ; Hoda SA
Am J Surg Pathol; 1999 Feb; 23(2):176-81. PubMed ID: 9989844
[TBL] [Abstract][Full Text] [Related]
23. High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: a preventive mechanism of malignant tumor cells against complement attack?
Hofman P; Hsi BL; Manie S; Fenichel P; Thyss A; Rossi B
Breast Cancer Res Treat; 1994; 32(2):213-9. PubMed ID: 7532466
[TBL] [Abstract][Full Text] [Related]
24. Pathology of the breast.
Litzky LA
Semin Roentgenol; 1993 Jul; 28(3):259-67. PubMed ID: 8211234
[No Abstract] [Full Text] [Related]
25. In breast cancer, a high ratio of tumour-infiltrating intraepithelial CD8+ to FoxP3+ cells is characteristic for the medullary subtype.
Anz D; Eiber S; Scholz C; Endres S; Kirchner T; Bourquin C; Mayr D
Histopathology; 2011 Nov; 59(5):965-74. PubMed ID: 22092408
[TBL] [Abstract][Full Text] [Related]
26. Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma.
Simsa P; Teillaud JL; Stott DI; Tóth J; Kotlan B
Pathol Oncol Res; 2005; 11(2):92-7. PubMed ID: 15999153
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
28. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.
Nielsen BS; Rank F; López JM; Balbin M; Vizoso F; Lund LR; Danø K; López-Otín C
Cancer Res; 2001 Oct; 61(19):7091-100. PubMed ID: 11585740
[TBL] [Abstract][Full Text] [Related]
29. Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast.
Kim M; Chung YR; Kim HJ; Woo JW; Ahn S; Park SY
Breast Cancer Res; 2020 Mar; 22(1):32. PubMed ID: 32216826
[TBL] [Abstract][Full Text] [Related]
30. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer.
Dall P; Heider KH; Sinn HP; Skroch-Angel P; Adolf G; Kaufmann M; Herrlich P; Ponta H
Int J Cancer; 1995 Feb; 60(4):471-7. PubMed ID: 7530237
[TBL] [Abstract][Full Text] [Related]
31. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
32. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
33. Histology and immunophenotype of invasive lobular breast cancer. daily practice and pitfalls.
Varga Z; Mallon E
Breast Dis; 2008-2009; 30():15-9. PubMed ID: 19850991
[TBL] [Abstract][Full Text] [Related]
34. Lymphoepithelioma-like carcinoma of the breast. An unusual pattern of infiltrating lobular carcinoma.
Cristina S; Boldorini R; Brustia F; Monga G
Virchows Arch; 2000 Aug; 437(2):198-202. PubMed ID: 10993283
[TBL] [Abstract][Full Text] [Related]
35. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
[TBL] [Abstract][Full Text] [Related]
36. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.
Mahmoud SM; Paish EC; Powe DG; Macmillan RD; Grainge MJ; Lee AH; Ellis IO; Green AR
J Clin Oncol; 2011 May; 29(15):1949-55. PubMed ID: 21483002
[TBL] [Abstract][Full Text] [Related]
37. Automated image morphometry of lobular breast carcinoma.
Rajesh L; Dey P; Joshi K
Anal Quant Cytol Histol; 2002 Apr; 24(2):81-4. PubMed ID: 12026054
[TBL] [Abstract][Full Text] [Related]
38. Lobular carcinoma-in-situ within a fibroadenoma of the breast.
Shah AK; Pathak R; Banerjee SN; Kaul A; Niazi M; Girishkumar HT
Postgrad Med J; 1999 May; 75(883):293-4. PubMed ID: 10533636
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.
Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC
J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750
[TBL] [Abstract][Full Text] [Related]
40. Pleomorphic lobular carcinoma of the breast with osteoclast-like giant cells: a case report and review of the literature.
Peña-Jaimes L; González-García I; Reguero-Callejas ME; Pinilla-Pagnon I; Pérez-Mies B; Albarrán-Artahona V; Martínez-Jañez N; Rosa-Rosa JM; Palacios J
Diagn Pathol; 2018 Aug; 13(1):62. PubMed ID: 30153845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
